Suche
Kategorie
Erscheinungsjahr
Bücher (18115)
140415 Treffer
×
Publikationen
- Kreuter, Abelina; Brunetti, Leonardo; Balcar, Lorenz et al.
- Role of Child-Turcotte-Pugh and ALBI scores in patients with noncirrhotic hepatocellular carcinoma
- JOURNAL OF HEPATOLOGY. Bd. 82. 2025
- Stefanini, Bernardo; Fulgenzi, Claudia Angela Maria; Scheiner, Bernhard et al.
- ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
- JOURNAL OF HEPATOCELLULAR CARCINOMA. Bd. 12. 2025 S. 671-683
- Sangro, Bruno; Kudo, Masatoshi; Decaens, Thomas et al.
- Outcomes by liver function in patients with unresectable hepatocellular carcinoma treated with nivolumab plus ipilimumab vs lenvatinib or sorafenib in the CheckMate 9DW trial
- JOURNAL OF HEPATOLOGY. Bd. 82. 2025
- Stefanini, Bernardo; Brunetti, Leonardo; Lombardi, Pasquale et al.
- Long-term survival outcomes in patients receiving atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma: an update of the AB-real study
- JOURNAL OF HEPATOLOGY. Bd. 82. 2025
- Mukhamedaliev, Umar; Galle, Peter R.; Strand., Susanne
- Modulation of mitotic stress-induced activation of the cGAS/ STING signaling pathway by DNA demethylation
- JOURNAL OF HEPATOLOGY. Bd. 82. 2025
- Graupera, Isabel; Thiele, Maja; Castera, Laurent et al.
- High prevalence of undiagnosed liver fibrosis in the adult european population driven by metabolic risk factors and alcohol consumption. results from the prospective liverscreen cohort in 30,541 subjects
- JOURNAL OF HEPATOLOGY. Bd. 82. 2025
- Yau, Thomas; Galle, Peter R.; Decaens, Thomas et al.
- Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3trial
- LANCET. Bd. 405. H. 10492. 2025 S. 1851-1864
- Cappuyns, Sarah; Pique-Gili, Marta; Esteban-Fabro, Roger et al.
- Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
- JOURNAL OF HEPATOLOGY. Bd. 82. H. 6. 2025
- Rodriguez, Isaac; Vellala, Abhinay; Itzel, Timo et al.
- Radiomics-based prediction of HCC response to atezolizumab/bevacizumab
- ONCOLOGY LETTERS. Bd. 30. H. 4. 2025
- Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro et al.
- Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence
- JHEP REPORTS. Bd. 7. H. 8. 2025